Table 1.
Correlation of DUSP4 expression with clinicopathological parameters in GC patients
| Variables | Cases (n) | DUSP4 expression | P | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Age | ||||
| ≤60 | 29 | 17 (58.6) | 12 (41.4) | 0.290 |
| >60 | 60 | 28 (46.7) | 32 (53.3) | |
| Gender | ||||
| Male | 69 | 39 (56.5) | 30 (43.5) | 0.037 |
| Female | 20 | 6 (30.0) | 14 (70.0) | |
| Tumour size (cm) | ||||
| ≤3.5 | 17 | 3 (17.6) | 14 (82.4) | 0.020 |
| >3.5 | 72 | 35 (48.6) | 37 (51.4) | |
| AJCC stage | ||||
| I+II | 37 | 17 (45.9) | 20 (54.1) | 0.463 |
| III+IV | 52 | 28 (53.8) | 24 (46.2) | |
| Depth of invasion | ||||
| Mucosa/Submucosa | 5 | 2 (40.0) | 3 (60.0) | 0.008 |
| Muscularis/Serosa/ | 84 | 72 (85.7) | 12 (14.3) | |
| T stage | ||||
| T1+T2 | 11 | 4 (36.4) | 7 (63.6) | 0.514 |
| T3+T4 | 78 | 21 (26.9) | 57 (73.1) | |
| N stage | ||||
| N0+N1 | 39 | 11 (28.2) | 28 (71.8) | 0.983 |
| N2+N3 | 50 | 14 (28.0) | 36 (72.0) | |
| M stage | ||||
| Negative | 84 | 24 (28.6) | 60 (71.4) | 0.016 |
| Positive | 5 | 4 (80.0) | 1 (20.0) | |